Compare Stocks

CGG is an integrated geosciences company, which provides geological geophysical and reservoir capabilities to its broad base of customers primarily from the global oil and gas industry. It manufactures geophysical equipment, as a provider of marine, land and airborne data acquisition services. The company operates its business through the following segments: Contractual Data Acquisition, Geology, Geophysics & Reservoir and Non-Operated Resources. The Contractual Data Acquisition segment comprises of Marine: offshore seismic data acquisition and Land and Multi-Physics and other seismic data acquisition. The Geology, Geophysics & Reservoir segment comprises the Multi-Client Business Line and the Subsurface Imaging and Reservoir business line. The Non-Operated Resources segment comprises the costs of the non-operated marine resources as well as all of the costs of its Transformation Plan .CGG was founded by Conrad Schlumberger on July 23, 1931 and is headquartered in Paris, France.

The Morgan Creek-Exos Active SPAC Arbitrage ETF (CSH) is an exchange-traded fund that mostly invests in extended market equity. The fund is actively managed to provide exposure to US-listed pre-combination special purpose acquisition companies (SPACs) through the use of common stock, warrants and rights. Positions will generally be in small- and mid-cap companies. CSH was launched on Feb 1, 2022 and is managed by Morgan Creek.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.